Adjuvant effect of antibodies against von Willebrand factor, fibrinogen, and fibronectin on staphylokinase-induced thrombolysis as measured using mural thrombi formed in rat mesenteric venules

Thrombosis Research

Volumn 97, Issue 5, 2000, Pages 327-333

  Yamamoto, Junichiro ^a   Kawano, Makiko ^a   Hashimoto, Masaru ^a   Sasaki, Yasuto ^a   Yamashita, Tsutomu ^a   Taka, Tomomi ^a   Watanabe, Sadahiro ^b   Giddings, John C ^c  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b KOBE CITY COLLEGE OF NURSING   (Japan)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Adhesive proteins; Arterial thrombosis; Platelet rich thrombi; Staphylokinase; Thrombolysis

Indexed keywords

FIBRINOGEN; FIBRONECTIN; STAPHYLOKINASE; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; MALE; MESENTERIC VEIN; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VENULE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BLOOD PRESSURE; FIBRINOGEN; FIBRINOLYTIC AGENTS; FIBRONECTINS; HEART DISEASES; IMMUNE SERA; IMMUNOGLOBULIN G; MALE; MESENTERIC VEINS; METALLOENDOPEPTIDASES; PLASMINOGEN ACTIVATORS; RATS; RATS, WISTAR; THROMBOLYTIC THERAPY; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 0033960604     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00184-X     Document Type: Article

References (36)

1. Fitzgerald D.J., Catella F., Roy L., Fitzgerald G.A. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 77:1988;142-150.
2. Coller B.S. Platelet and thrombolytic therapy. N Eng J Med. 322:1990;33-42.
3. Kawano M., Watanabe S., Sasaki Y., Giddings J.C., Yamamoto J. Adjuvant effect of argatroban on staphylokinase induced thrombolysis of platelet rich thrombi in rat mesenteric venules in vivo. Thromb Res. 86:1997;115-126.
4. Weiss H.J., Turitto V.T., Baumgartner H.R. Effect of shear rate on platelet interaction with subendothelium in citrate and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome. J Lab Clin Med. 92:1978;750-764.
5. Baumgartner H.R., Tschopp T.B., Meyer D. Shear rate dependent inhibition of platelet adhesion and aggregation of collagenous surfaces by antibodies to human factor VIII/von Willbrand factor. Br J Haematol. 44:1980;127-139.
6. Peterson D.M., Stathopoulos N.A., Giorgio T.D., Hellumus J.D., Moake J.L. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 69:1987;625-628.
7. Weiss J.J., Hawiger J., Ruggeri Z.M., Turitto V.T., Thiagarajan P., Hoffmann T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest. 83:1989;288-297.
8. Ikeda Y., Handa M., Kawano K., Kamata T., Murata M., Araki Y., Anbo H., Kawai Y., Watanabe K., Itagaki I., Sakai K., Ruggeri Z.M. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 87:1991;1234-1240.
9. Ikeda Y., Handa M., Kamata T., Kawano K., Kawai Y., Watanabe K., Kawakami K., Sakai K., Fukuyama M., Itagaki I., Yoshioka A., Ruggeri Z.M. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost. 69:1993;496-502.
10. Beumer S., Ijsseldijk M.J.W., Groot P.G., Sixma J.J. Platelet adhesion to fibronectin in flow. dependence on surface concentration and shear rate, role of platelet menbrane glycoproteins GPIIb/IIIa and VLA-5, and inhibition by heparin Blood. 84:1994;3724-3733.
11. Yamamoto J., Oyama T., Ishii I., Okita N., Sasaki Y., Yamashita T., Matsuoka A., Muraki T., Giddings J.C., Watanabe S., Seki J. The differential involvement of von Willebrand factor, fibrinogen and fibronectin in acute experimental thrombosis in rat cerebral and mesenteric microvessels. Jpn J Physiol. 47:1997;431-441.
12. Folts J.D., Crowell E.B., Rowe G.G. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 54:1976;365-370.
13. Haskel E.J., Prager N.A., Sobel B.E., Abendschein D.R. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion. Circulation. 83:1991;1048-1056.
14. Gold H.K., Yasuda T., Jang I., Guerrero J.L., Fallon J.T., Leinbach R.C., Collen D. Animal models for arterial thrombolysis and prevention of reocclusion. Circulation. 83(Suppl IV):1991;IV26-IV40.
15. Strony J., Song A., Rusterholtz L., Adelman B. Aurintricarboxylic acid prevents acute rethrombosis in a canine model of arterial thrombosis. Arterioscler Thromb Vasc Biol. 15:1995;359-366.
16. Nishiyama H., Umemura K., Saniabadi A.R., Takiguchi Y., Uematsu T., Nakashima M. Enhancement of thrombolytic efficacy of tissue-type plasminogen activator by adjuvants in the guinea pig thrombosis model. Eur J Pharmacol. 264:1994;191-198.
17. Stockmans F., Deckmyn H., Gruwez J., Vermylen J., Acland R. Continuous qunatitative monitouring of mural, platelet-dependent, thrombus kinetics in the crushed rat femoral vein. Thromb Haemost. 65:1991;425-431.
18. Rosenblum W.I., El-Sabban F. Platelet aggregation in the cerebral microcirculation. effect of aspirin and other agents Circ Res. 40:1977;320-328.
19. Kovacs I.B., Tigyi-Sebes A., Trombitas K., Gorog P. Evans blue. An ideal energy-absoring material to produce intravascular microinjury by He-Ne gas laser Microvasc Res. 10:1975;107-124.
20. Yamamoto J., Iizumi H., Hirota R., Shimonaka K., Nagamatsu Y., Horie N., Morita S. Effect of physical training on thrombotic tendency in rats. decrease in thrombotic tendency measured by the He-Ne laser-induced thrombus formation method Haemostasis. 19:1989;260-265.
21. Sasaki Y., Seki J., Giddings J.C., Yamamoto J. Effects of NO-donors on thrombus formation and microcirculation in cerebral vessels of the rat. Thromb Haemost. 76:1996;111-117.
22. Geng J.-H., Bevilacqua M.P., Moore K.L., McIntyre T.M., Prescott S.M., Kim J.M., Bliss G.A., Zimmerman G.A., McEver R.P. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature. 343:1990;757-760.
23. Palabrica T., Lobb R., Furie B.C., Aronovitz M., Benjamin C., Hsu Y.-M., Sajer S.A., Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 359:1992;848-851.
24. Montrucchio G., Lupia E., De Martino A., Silvestro L., Savu S.R., Cacace G., De Filippi P.G., Emanuelli G., Camussi G. Plasmin promotes an endothelium-dependent adhesion of neutrophils. Circulation. 93:1996;2152-2160.
25. Ueyama T., Ikeda H., Haramaki N., Kuwano K., Imaizumi T. Effects of monoclonal antibody to P-selectin and analogue of sialyl lewis X on cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation. 95:1997;1554-1559.
26. Bajzar L., Morser J., Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem. 271:1996;16603-16608.
27. Bajzar L., Nesheim M.E., Tracy P.B. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood. 88:1996;2093-2100.
28. Nesheim M., Wang W., Boffa M., Nagashima M., Morser J., Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost. 78:1997;386-391.
29. Griffin J.H. Blood coagulation. The thrombin paradox. Nature. 378:1997;337-338.
30. Minnema M.C., Friederich P.W., Levi M., Kr. von dem Borne P.A., Mosnier L.O., Meijers J.C.M., Biemond B.J., Hack C.E., Bouma B.N., Cate H.T. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. J Clin Invest. 101:1998;10-14.
31. Malavasi F., Tetta C., Funaro A., Bellone G., Ferrero E., Franzone A.C., Dellabona P., Rusci R., Matera L., Camussi G., Caligaris-Cappio F. Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. Proc Natl Acad Sci USA. 83:1986;2443-2447.
32. Matsuo S., Ichida S., Takizawa H., Okada N., Baranyi L., Iguchi A., Morgan B.P., Okada H. In vivo effects of monoclonal antobodies that functionally inhibit complement regulatory proteins in rats. J Exp Med. 180:1994;1619-1627.
33. Ravetch J.V., Clynes R.A. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol. 16:1998;421-432.
34. Sako T. Overproduction of staphylokinase in Esherichia coli and its characterization. Eur J Biochem. 149:1985;557-563.
35. Lijinen H.R., Hoef B.V., Cock F.D., Okada K., Ueshima S., Matsuo O., Collen D. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem. 266:1991;11826-11832.
36. Matsuo O., Okada K., Fukao H., Tomioka Y., Ueshima S., Watanuki M., Sakai M. Thrombolytic properties of staphylokinase. Blood. 76:1990;925-929.